Peripheral fundus findings in X-linked retinoschisis
- PMID: 28348004
- DOI: 10.1136/bjophthalmol-2016-310110
Peripheral fundus findings in X-linked retinoschisis
Abstract
Background/aims: Vitreous haemorrhage (VH) and retinal detachment (RD) cause a precipitous decline in vision in a subset of patients with X-linked retinoschisis (XLRS), an otherwise a slowly progressive condition. This study aims to report the frequency of macular and peripheral retinal findings in a large cohort of patients with XLRS and to determine whether peripheral retinal findings are associated with VH and RD.
Methods: A retrospective observational case series was performed in 65 patients with XLRS with a pathogenic variant in retinoschisin 1. Chart review included examination notes, fundus photographs and optical coherence tomography (OCT). Fisher exact tests and univariable logistic regression analysis were used to determine the association between peripheral retinal findings (including retinoschisis, metallic sheen, vascular sheathing, pigmentary changes, white spiculations and vitreous veils) and complications (including VH and RD).
Results: Seven eyes (8%) showed normal macular structure on OCT. Peripheral retinoschisis was significantly associated with both VH and RD. Out of 10 eyes with complications, 9 (90%) had peripheral retinoschisis, compared with 33 out of 116 eyes (28%) without complications (p=0.0014). In addition, each additional peripheral finding increased the odds of RD by a factor of 4.06 (95% CI 1.58 to 10.39, p=0.028). There were no complications in the 28 eyes with a normal periphery (p=0.84) or in the 35 eyes with metallic sheen (p=0.42).
Conclusion: The data suggest that patients with peripheral retinoschisis are at increased risk for VH and RD. Furthermore, patients with additional peripheral retinal findings together with peripheral schisis may carry additional risk for RD.
Keywords: Dystrophy; Genetics; Retina.
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
Conflict of interest statement
Competing interests: ATF owns stock in Ionis Pharmaceuticals (Carlsbad, CA). MM consults for Meira GTx (London, UK), Ora Inc (Andover, MA), Shire (Hampshire, UK) and Editas (Cambridge, MA). NA and TB have no financial disclosures.
Similar articles
-
Phenotypic Characteristics of a French Cohort of Patients with X-Linked Retinoschisis.Ophthalmology. 2018 Oct;125(10):1587-1596. doi: 10.1016/j.ophtha.2018.03.057. Epub 2018 May 5. Ophthalmology. 2018. PMID: 29739629
-
Phenotypic characterization of X-linked retinoschisis: Clinical, electroretinography, and optical coherence tomography variables.Indian J Ophthalmol. 2016 Jul;64(7):513-7. doi: 10.4103/0301-4738.190140. Indian J Ophthalmol. 2016. PMID: 27609164 Free PMC article.
-
Genotype-Phenotype Correlations in 83 Korean X-linked Retinoschisis Patients: Impact of Retinoschisin 1 Secretion Profiles on Clinical Phenotypes.Ophthalmol Retina. 2025 Mar;9(3):288-298. doi: 10.1016/j.oret.2024.09.007. Epub 2024 Sep 16. Ophthalmol Retina. 2025. PMID: 39293640
-
Typical and atypical clinical presentations of X-Linked retinoschisis: A case series and literature review.Surv Ophthalmol. 2023 May-Jun;68(3):347-360. doi: 10.1016/j.survophthal.2023.01.008. Epub 2023 Jan 29. Surv Ophthalmol. 2023. PMID: 36724832 Review.
-
Review: Clinical findings and genetic characterization of children affected with X-linked retinoschisis in the Spanish population.Eur J Ophthalmol. 2025 May;35(3):809-820. doi: 10.1177/11206721241305244. Epub 2024 Dec 8. Eur J Ophthalmol. 2025. PMID: 39648411 Review.
Cited by
-
Macular dystrophies: clinical and imaging features, molecular genetics and therapeutic options.Br J Ophthalmol. 2020 Apr;104(4):451-460. doi: 10.1136/bjophthalmol-2019-315086. Epub 2019 Nov 8. Br J Ophthalmol. 2020. PMID: 31704701 Free PMC article. Review.
-
Clinical and Genetic Study of X-Linked Juvenile Retinoschisis in the Czech Population.Genes (Basel). 2021 Nov 18;12(11):1816. doi: 10.3390/genes12111816. Genes (Basel). 2021. PMID: 34828422 Free PMC article.
-
A retrospective longitudinal study of 52 Finnish patients with X-linked retinoschisis.Acta Ophthalmol. 2025 Mar;103(2):196-204. doi: 10.1111/aos.16776. Epub 2024 Oct 22. Acta Ophthalmol. 2025. PMID: 39435478 Free PMC article.
-
Long-term functional and structural outcomes in X-linked retinoschisis: implications for clinical trials.Front Med (Lausanne). 2023 Jun 15;10:1204095. doi: 10.3389/fmed.2023.1204095. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37396901 Free PMC article.
-
Carbonic anhydrase inhibitors limit complications in X-linked retinoschisis.Front Med (Lausanne). 2023 Nov 6;10:1281068. doi: 10.3389/fmed.2023.1281068. eCollection 2023. Front Med (Lausanne). 2023. PMID: 38020097 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous